A. Dhople

发表

Serum angiotensin-converting enzyme in leprosy.

E. E. Storrs, S. Williams, J. A. Zeigler, 1985, Indian journal of leprosy.

Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.

E. E. Storrs, A. Dhople, 1982, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Microscopic counts carried out on Mycobacterium leprae and M. tuberculosis suspensions. A comparison of three staining procedures.

S. Watson, N. Morrison, F. Collins, 1980, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Pedigreed stocks of Mycobacterium lepraemurium for cultivation and metabolic studies.

J. H. Hanks, A. Dhople, 1980, Canadian journal of microbiology.

In vitro growth of Mycobacterium lepraemurium, an obligate intracellular microbe.

J. H. Hanks, A. Dhople, 1977, Science.

Energetics (Adenosine 5′-Triphosphate) of Mycobacterium lepraemurium in Diffusion Chambers Incubated In Vitro and in Mice

J. H. Hanks, A. Dhople, 1973, Infection and immunity.

Quantitative extraction of adenosine triphosphate from cultivable and host-grown microbes: calculation of adenosine triphosphate pools.

A. M. Dhople, J. H. Hanks, A. Dhople, 1973, Applied microbiology.

The activity of rifabutin against Mycobacterium leprae in armadillos.

S. Williams, A. Dhople, 1997, International journal of antimicrobial agents.

Acid tolerance of Escherichia coli O157:H7 and its survival in apple juice.

L. Koodie, A. Dhople, 2001, Microbios.

Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors.

M. Kansy, M. Wiese, K. Schaper, 1986, Leprosy review.

Quantitative Extraction of Adenosine Triphosphate from Cultivable and Host-Grown Microbes: Calculation of Adenosine Triphosphate Pools

J. H. Hanks, A. Dhople, 1973 .

Activities of Sitafloxacin (DU-6859a), Either Singly or in Combination with Rifampin, Against Mycobacterium ulcerans Infection in Mice

A. M. Dhople, K. Namba, A. Dhople, 2003, Journal of chemotherapy.

ATP content of Mycobacterium tuberculosis grown in vivo and in vitro.

A. Dhople, D. Ryon, 2000, Microbios.

In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.

A. Dhople, 2002, International journal of antimicrobial agents.

Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.

A. M. Dhople, A. Dhople, 2001, The Journal of antimicrobial chemotherapy.

In vivo Susceptibility of Mycobacterium ulcerans to KRM-1648, a New Benzoxazinorifamycin, in Comparison with Rifampicin

A. Dhople, 2001, Arzneimittelforschung.

The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.

A. M. Dhople, M. A. Ibáñez, A. Dhople, 1995, The Journal of antimicrobial chemotherapy.

In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans.

A. Dhople, 2001, International journal of antimicrobial agents.

In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.

M. A. Ibáñez, A. Dhople, 1995, Indian journal of leprosy.

Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.

A. Dhople, 1984, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

In-vitro activity of three new fluoroquinolones and synergy with ansamycins against Mycobacterium leprae.

M. A. Ibáñez, A. Dhople, 1993, The Journal of antimicrobial chemotherapy.

Polyunsaturated Fatty Acids in Leprosy.

N. Magar, A. Dhople, 1961 .

In vitro and in vivo Activity of K-130, a Dihydrofolate Reductase inhibitor, against Mycobacterium leprae

A. Dhople, 1999, Arzneimittelforschung.

Search for newer antileprosy drugs.

A. M. Dhople, A. Dhople, 2000, Indian journal of leprosy.

In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.

A. Dhople, 1999, International journal of antimicrobial agents.

Liver function tests in leprosy.

S. Balakrishnan, A. Dhople, 1968 .

Intrabacterial sodium-to-potassium ratios and ATP contents of Mycobacterium leprae from ofloxacin-treated patients.

B. Lindner, U. Seydel, M. Haas, 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Role of iron in the pathogenesis of Mycobacterium avium infection in mice.

A. M. Dhople, M. Ibáñez, T. C. Poirier, 1996, Microbios.

In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae

A. M. Dhople, M. A. Ibáñez, A. Dhople, 1995, Antimicrobial agents and chemotherapy.

Mycobacterium leprae . combination with rifamycin analogs , against In vitro activity of levofloxacin , singly and in

A. Dhople, M. A. Ibanez, 1995 .